Leenah Abdulgader, Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Ghazi Alharbi, Saad Al Awwad
{"title":"Primary hyperparathyroidism due to water-clear cell carcinoma of the parathyroid gland: a case report and literature review.","authors":"Leenah Abdulgader, Abdullah Esmail, Bayan Khasawneh, Ebtesam Al-Najjar, Ghazi Alharbi, Saad Al Awwad","doi":"10.21037/cco-25-25","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Water-clear cell carcinoma of the parathyroid gland is an exceedingly rare malignancy, with the majority of published cases focusing on adenomas that are typically large and associated with mild elevations in parathyroid hormone (PTH) levels.</p><p><strong>Case description: </strong>We present the case of a 43-year-old woman who presented with a pelvic pathological fracture and very high serum calcium of 15.5 mg/dL, along with a severely elevated PTH level (>2,500 pg/mL). Imaging studies, including ultrasound, computed tomography (CT), and technetium-99m sestamibi (99mTc-MIBI) subtraction scintigraphy, revealed a mass in the inferior parathyroid gland on the left side of the thyroid gland. The patient underwent surgical resection, and the excised tumor measured 3 cm × 2.5 cm × 1.5 cm and weighed 10.7 grams. Histopathological examination confirmed the diagnosis of water-clear cell carcinoma of the parathyroid gland, with prominent vascular invasion.</p><p><strong>Conclusions: </strong>This case is particularly significant as it represents the largest water-clear cell carcinoma of the parathyroid gland reported in the literature to date. The patient was closely monitored postoperatively, and at 1-year follow-up, there were no signs of distant metastases or recurrence of hyperparathyroidism. This case underscores the aggressive nature of water-clear cell carcinoma, highlighting the need for early detection and prompt surgical intervention in such rare and potentially life-threatening tumors.</p>","PeriodicalId":9945,"journal":{"name":"Chinese clinical oncology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cco-25-25","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Water-clear cell carcinoma of the parathyroid gland is an exceedingly rare malignancy, with the majority of published cases focusing on adenomas that are typically large and associated with mild elevations in parathyroid hormone (PTH) levels.
Case description: We present the case of a 43-year-old woman who presented with a pelvic pathological fracture and very high serum calcium of 15.5 mg/dL, along with a severely elevated PTH level (>2,500 pg/mL). Imaging studies, including ultrasound, computed tomography (CT), and technetium-99m sestamibi (99mTc-MIBI) subtraction scintigraphy, revealed a mass in the inferior parathyroid gland on the left side of the thyroid gland. The patient underwent surgical resection, and the excised tumor measured 3 cm × 2.5 cm × 1.5 cm and weighed 10.7 grams. Histopathological examination confirmed the diagnosis of water-clear cell carcinoma of the parathyroid gland, with prominent vascular invasion.
Conclusions: This case is particularly significant as it represents the largest water-clear cell carcinoma of the parathyroid gland reported in the literature to date. The patient was closely monitored postoperatively, and at 1-year follow-up, there were no signs of distant metastases or recurrence of hyperparathyroidism. This case underscores the aggressive nature of water-clear cell carcinoma, highlighting the need for early detection and prompt surgical intervention in such rare and potentially life-threatening tumors.
期刊介绍:
The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.